# HIV Non Occupational Post-Exposure Prophylaxis (PEP)

> **NCT00594646** · PHASE4 · COMPLETED · sponsor: **Fenway Community Health** · enrollment: 100 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** TRUVADA + Raltegravir

## Key facts

- **NCT ID:** NCT00594646
- **Lead sponsor:** Fenway Community Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2010-03
- **Final completion:** 2010-08
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2022-10-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00594646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00594646, "HIV Non Occupational Post-Exposure Prophylaxis (PEP)". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00594646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*